Lorcaserin Extended-Release Tablets and Onasemnogene abeparvovec Zolgensma
Determining the interaction of Lorcaserin Extended-Release Tablets and Onasemnogene abeparvovec Zolgensma and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Oncaspar
- Lorcaserin Extended-Release Tablets-Oncovin
- Lorcaserin Extended-Release Tablets-Ondansetron
- Lorcaserin Extended-Release Tablets-Ondansetron and Dextrose
- Lorcaserin Extended-Release Tablets-Ondansetron Hydrochloride
- Lorcaserin Extended-Release Tablets-Ondansetron injection
- Onasemnogene abeparvovec Zolgensma-Lorcaserin Hydrochloride
- Onasemnogene abeparvovec Zolgensma-Lorcaserin Tablets
- Onasemnogene abeparvovec Zolgensma-Lorcet
- Onasemnogene abeparvovec Zolgensma-Lorcet Plus
- Onasemnogene abeparvovec Zolgensma-Lorcet Tablets
- Onasemnogene abeparvovec Zolgensma-Lorlatinib